当前位置: X-MOL 学术Allergy › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Artemisia annua sublingual immunotherapy for seasonal allergic rhinitis: a randomized controlled trial
Allergy ( IF 12.6 ) Pub Date : 2020-02-23 , DOI: 10.1111/all.14218
Hongfei Lou 1, 2 , Yanran Huang 1, 2 , Yuhui Ouyang 2, 3 , Yuan Zhang 2, 3 , Lin Xi 2, 3 , Xiaohan Chu 1, 2 , Yang Wang 2 , Chengshuo Wang 1, 2 , Luo Zhang 1, 2, 3
Affiliation  

Artemisia annua is an important autumnal pollen allergen for seasonal allergic rhinitis (SAR) in northern China. To date, no study has investigated allergen immunotherapy with A annua. We aimed to investigate the efficacy and mechanisms underlying A annua‐sublingual immunotherapy (SLIT).
更新日期:2020-02-23
down
wechat
bug